Stock 4BAX BAXTER INTERNATIONAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Baxter International Inc. Borsa Italiana

Equities

4BAX

US0718131099

End-of-day quote Borsa Italiana
Other stock markets
 23:00:00 19/06/2024 BST 		5-day change 1st Jan Change
31.78 EUR +1.37% Intraday chart for Baxter International Inc. +0.78% -9.21%
06-20 Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors CI
06-12 Transcript : Baxter International Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:40 AM

Strengths

  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
BAXTER INTERNATIONAL INC. Stock Baxter International Inc.
-9.21% 17.42B -
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.16% 183B
C+
MEDTRONIC PLC Stock Medtronic plc
-2.39% 104B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.08% 68.18B
A
CENCORA, INC. Stock Cencora, Inc.
+16.04% 47.14B
B-
DEXCOM, INC. Stock DexCom, Inc.
-11.10% 43.97B
B-
HOYA CORPORATION Stock Hoya Corporation
+6.70% 40.95B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+17.63% 31.05B
B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-8.10% 24.11B
A-
TERUMO CORPORATION Stock Terumo Corporation
+12.48% 24.05B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. BAX Stock
  4. 4BAX Stock
  5. Ratings Baxter International Inc.